Crossmark

What Is the Role of Additional Pharmacotherapy and Neuromodulation in Patients with Marginal Benefit from Botulinum Toxin Injection?

Crossref DOI link: https://doi.org/10.1007/s11934-018-0842-8

Published Online: 2018-09-08

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zahner, Patricia M.

Giusto, Laura L.

Goldman, Howard B.
License Information

Text and Data Mining valid from 2018-09-08
More Information

Article History

First Online: 8 September 2018

Compliance with Ethical Standards

:

: Patricia M. Zahner and Laura L. Giusto each declare no potential conflicts of interest.

: This article does not contain any studies with human or animal subjects performed by any of the authors.